International Journal on Science and Technology

E-ISSN: 2229-7677   •   Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 16 Issue 2 April-June 2025 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 16 Issue 2
2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Clinical spectrum of inflammatory bowel disease in Kashmiri Population: A prospective study in a tertiary care hospital

Author(s) Waseem javid, Showkat ahmad kadla, Nisar ahmad shah
Country India
Abstract Background and objectives: The global incidence of inflammatory bowel disease (IBD), Ulcerative colitis (UC) and Crohn’s disease (CD) is on the rise. We don’t have any epidemiological or descriptive data especially in Kashmir valley, India. The objective of this study is to identify socio-demographic and clinical characteristics among patients with IBD attending Tertiary hospital in Kashmir, India.
Methods: The current study was a hospital based prospective cross sectional observational study. It was conducted in the department of Gastroenterology, GMC Srinagar, Jammu and Kashmir, India. We applied a Questionnaire for patients diagnosed with IBD. We focussed on the socio-demographic and clinical variables of each patient.
Results: 100 patients with IBD whose age was more than 17 years were included in this study. Fifty seven of them (57%) were UC and forty three (43%) CD. The mean age of patients with UC was 38.7±6.19 years and 35.3±5.62 years for patients with CD. 48% of patients were males and 52% were females. The male/female distribution was 1.48:1 for UC and 1.45:1 for CD. The most common first presentation of UC and CD were bloody stools (63.2%) and pain abdomen (40%) respectively. Extra intestinal manifestations were present in 58% of UC and 42% of CD patients. CD mostly affected the terminal ileum location (L1) (60.5%). CD patients with stricture (18.6%), fistula (11.6) and /or perianal disease (11.6%) were mostly female and younger at diagnosis. Left sided colitis was the most common extension of UC (62%). Most of CD and UC patients were under treatment with different pharmacological agents which includes 5-ASA (71%), followed by Thiopurines (47%), steroids (50%) and anti- TNF therapy(16%). Majority of our patients are on follow up and in remission (97%) and three of UC patients (5.3%) died of COVID -19 infections mostly were elderly with severe disease.
Conclusion: Diagnostic delay is still a big concern, leading to more complicated disease. The higher proportion of complicated CD and extensive UC resulted in a greater need for healthcare resources in this cohort such as hospitalisation, surgery and biological treatment.
Keywords Inflammatory bowel disease, UC, CD, Thiopurines, Biologicals, COVID-19
Field Medical / Pharmacy
Published In Volume 16, Issue 1, January-March 2025
Published On 2025-01-28
Cite This Clinical spectrum of inflammatory bowel disease in Kashmiri Population: A prospective study in a tertiary care hospital - Waseem javid, Showkat ahmad kadla, Nisar ahmad shah - IJSAT Volume 16, Issue 1, January-March 2025. DOI 10.71097/IJSAT.v16.i1.1597
DOI https://doi.org/10.71097/IJSAT.v16.i1.1597
Short DOI https://doi.org/g83jhb
View / Download PDF File

Share this



CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJSAT DOI prefix is
10.71097/IJSAT

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 15 Isu 4Cover Page Vol 15 Isu 3Cover Page Vol 15 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJSAT
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us Message on WhatsApp +91-9687-182-185 editor@ijsat.org